Profile
Nicholas Siciliano is the founder of Invisible Sentinel, Inc. which was founded in 2006.
He held the title of Chief Executive Officer & Director at the company from 2006 to 2022.
Dr. Siciliano is also the founder of viTToria Biotherapeutics, Inc.
Nicholas Siciliano active positions
Companies | Position | Start |
---|---|---|
ViTToria Biotherapeutics, Inc.
ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Founder | - |
Former positions of Nicholas Siciliano
Companies | Position | End |
---|---|---|
Invisible Sentinel, Inc.
Invisible Sentinel, Inc. BiotechnologyHealth Technology Invisible Sentinel, Inc. engages in food diagnostics. It offers food safety, wine, beer products such as veriflow for salmonella, listerria species and vinoBrett for breetanomyces bruxellensis, vinoPAL for pedicoccus and lactobacillus and veriflow custom solutions. The company was founded by Nicholas Siciliano and Benjamin Pascal in October 2006 and is headquartered in Philadelphia, PA. | Founder | 2021-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Invisible Sentinel, Inc.
Invisible Sentinel, Inc. BiotechnologyHealth Technology Invisible Sentinel, Inc. engages in food diagnostics. It offers food safety, wine, beer products such as veriflow for salmonella, listerria species and vinoBrett for breetanomyces bruxellensis, vinoPAL for pedicoccus and lactobacillus and veriflow custom solutions. The company was founded by Nicholas Siciliano and Benjamin Pascal in October 2006 and is headquartered in Philadelphia, PA. | Health Technology |
ViTToria Biotherapeutics, Inc.
ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Nicholas Siciliano